With Lab Hub, Blue Bell's
Halfpenny Technologies hopes to take Health Information Exchange technology to the next level, integrating features like computerized order entry and results reporting with the company's already-respected exchange tools. With a little help from their friends, Halfpenny may be ready to deliver this turnkey technology sooner than expected as the company announced two big steps forward last week.
First came a $2.6 million venture capital investment. Locals like Bala Cynwyd-based
Osage Venture Partners and
LORE (Loosely Organized Retired Executives) Associates partnered with New York-based
Milestone Venture Partners to put support behind Lab Hub. Investors believe the financing will help push Lab Hub over the finish line.
"Halfpenny's strong technology platform, domain expertise and solid business strategy combined with its growing client base have positioned the company to move to the next level, says Osage Venture Partners vice president David Drahms.
"We look forward to partnering with Halfpenny in meeting the needs of the evolving healthcare market."
Halfpenny also announced the addition of four industry veterans to the Halfpenny Management Team. New team members include , executive vice president of business development Mitch Fry; chief financial officer Daniel O'Brien; senior vice president of sales Roger Newbury; and vice president of sales Jim Sheils. While trying to establish Lab Hub in new markets, Halfpenny officials hope these experienced team members can keep things growing.
"All of our new team members have impressive track records in healthcare and understand the complex challenges facing the industry today," says Halfpenny chief sales officer Bob Cox. "We are pleased to be able to draw upon the strategic vision and in-depth understanding of these healthcare veterans and look forward to their insights and ideas as we continue to develop solutions that address ever-expanding laboratory outreach, HIE and REC initiatives."
Source: Bob Cox, Halfpenny Technologies
Writer: John Steele